515 filings
Page 6 of 26
CORRESP
fg7034r med
21 Mar 18
Correspondence with SEC
12:00am
3
mdrhb137i7
16 Mar 18
GT Biopharma / Shawn Cross ownership change
12:00am
CORRESP
7t3kc1n rq3enrz
15 Mar 18
Correspondence with SEC
12:00am
8-K/A
vuk8es2vl1jqj
15 Mar 18
Amendments to Articles of Incorporation or Bylaws
12:00am
UPLOAD
qniwkaog
12 Mar 18
Letter from SEC
12:00am
UPLOAD
8cbak
12 Mar 18
Letter from SEC
12:00am
8-K
5oy ztlbcezmwu0ha
21 Feb 18
Entry into a Material Definitive Agreement
12:00am
SC 13G/A
4d6fzx
7 Feb 18
GT Biopharma, Inc.
12:00am
D
r8tl3 31ax19b0
6 Feb 18
$7.06M in debt / options, sold $7.06M, 14 investors
12:00am
8-K
ejb fzlz2
23 Jan 18
Entry into a Material Definitive Agreement
12:00am